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Abstract
Background: The cause of low serum vitamin D concentrations in dogs with chronic
inflammatory enteropathy (CIE) is not well understood.
Objective: Improve understanding of pathogenesis of low serum vitamin D concen-
trations in dogs with CIE by comparing several clinical, clinicopathologic, and histo-
logic variables between CIE dogs with low and normal serum 25-hydroxyvitamin D
concentrations (25[OH]D).
Animals: Fifteen dogs with CIE and low serum 25[OH]D concentrations; 15 dogs
with CIE and normal serum 25(OH)D concentrations.
Methods: Prospective cohort study. Clinical and clinicopathologic variables were
compared between groups. Correlations between serum 25(OH)D concentration and
histopathologic variables were assessed.
Results: Dogs with CIE and low serum 25(OH)D concentrations had higher canine
chronic enteropathy clinical activity index scores (P = .003), lower serum
α-tocopherol (P < .001), cholesterol (P < .001), and albumin (P < .001) concentra-
tions and higher serum C-reactive protein (P = .004) concentrations compared to
CIE dogs with normal serum 25(OH)D concentrations. Serum concentrations of
vitamin D-binding protein (VDBP) were not different between groups (P = .91).
Duodenal morphologic and inflammatory histopathological scores (P = .002 and
P = .004, respectively) and total histopathological scores in duodenum and
combined duodenum and ileum negatively correlated with serum 25(OH)D
concentration.
Conclusions and Clinical Importance: The pathogenesis of low serum vitamin D
concentrations in dogs with CIE is likely multifactorial. Fat malabsorption
deserves further study in dogs with low serum vitamin D concentration and CIE.
Abbreviations: 25[OH]D, serum 25-hydroxyvitamin D; CCECAI, canine chronic enteropathy clinical activity index; CE, chronic enteropathy; CIE, chronic inflammatory enteropathy; CD, Crohn's
disease; CRP, C reactive protein; CSU, Colorado State University; DACPAH, Michigan State University's Diagnostic Center for Population and Animal Health; DMB, dry matter basis;
DOI, duration of illness; IBD, inflammatory bowel disease; LD, lacteal dilatation; OR, odds ratio; PLE, protein-losing enteropathy; RI, reference interval; VDBP, vitamin D-binding protein;
WSAVA, World Small Animal Veterinary Association.
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Loss of VDBP does not appear to be an important cause of low serum vitamin D
concentration in dogs with CIE.
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1 | INTRODUCTION
Decreased serum 25-hydroxyvitamin D (25[OH]D) concentrations have
been well documented in dogs with chronic inflammatory enteropathy
(CIE) and protein-losing enteropathy (PLE),1-3 and have been associated
with poor outcome.4 Similarly, children and adults with inflammatory
bowel disease (IBD), specifically Crohn's disease (CD), are more likely to
be vitamin D deficient than healthy controls5-8 and can experience
poorer quality of life9 and increased risk for hospitalization and surgery.10
Proposed mechanisms for vitamin D deficiency in human patients
with IBD include decreased exposure to sunlight, decreased PO
vitamin D intake, malabsorption, loss of vitamin D through the intesti-
nal tract, and the presence of an active inflammatory state.11 Oral intake
of vitamin D has not been consistently correlated with hypovitaminosis D
in human patients with IBD.11One group of researchers found an approxi-
mately 30% decrease in absorption of PO administered vitamin D2 in
patients with CDwhen compared to healthy controls,12 but in other stud-
ies intestinal absorption of vitamin D was found to be normal in most
patients with IBD.13,14 A systematic review and meta-analysis found that
in addition to vitamin D, concentrations of other fat-soluble vitamins (A, E,
and K) are decreased in CD patients compared to healthy controls.15
Direct loss of vitamin D has been suggested as a mechanism, but
vitaminDmetabolites are primarily transported in the circulation bound to
vitamin D-binding protein (VDBP [85%-90%]), and to a lesser extent albu-
min (10%-15%).16 Concentrations of VDBPwere decreased in a cohort of
children with IBD compared to healthy controls,17 and in another study,
serum 25(OH)D concentration was positively correlated with serum albu-
min concentration in a group of 130 children and young adults with IBD.18
In dogs with CIE, the cause of low serum vitamin D concentration
is not fully understood.1 Decreased dietary intake of vitamin D may
be a contributing factor, but 1 study found that dogs with decreased
appetite and non-gastrointestinal illness had higher serum 25(OH)D con-
centrations than did dogs with chronic enteropathy (CE), suggesting that
poor appetite does not always lead to decreased serum vitamin D con-
centrations.2 In 33 dogs with CE, a relationship between serum albumin
and serum 25(OH)D concentrations was found.2 Additionally, markers of
systemic and intestinal inflammation have been negatively associated
with serum 25(OH)D concentrations in dogs with CE.19 Serum concen-
tration of VDBP and other fat-soluble vitamins have not been reported
previously in dogs with hypovitaminosis D and CIE.
Determining the relationship of clinical, clinicopathologic, and his-
topathologic variables with serum 25(OH)D concentrations in dogs
with CIE may lead to a better understanding of why vitamin D
decreases in this cohort and improve our ability to detect and treat
low serum vitamin D concentrations. Therefore, our objective was to
evaluate variables associated with intake of vitamin D, concentrations
of other fat-soluble vitamins, concentrations of vitamin D serum-
binding proteins, and markers of systemic and intestinal inflammation
in dogs with CE and low or normal serum 25(OH)D concentrations.
2 | MATERIALS AND METHODS
2.1 | Study population
Dogs presented to Colorado State University (CSU) Veterinary Teaching
Hospital for evaluation of chronic gastrointestinal signs of >3 weeks'
duration were eligible for inclusion in the study. Expressed written con-
sent was obtained from the owners of each of the study participants.
Dogs were eligible for inclusion if diagnostic evaluation consisting of
hematology, serum biochemical profile, and abdominal ultrasonography
excluded non-gastrointestinal illness and histopathologic evidence of
small intestinal disease characterized by inflammatory infiltrates andmor-
phologic changes were present. Dogs with histopathologic evidence of
intestinal neoplasia were excluded. Urinalysis with or without urine pro-
tein:creatinine ratio and fasting and postprandial bile acids were per-
formed to exclude other causes of hypoalbuminemia in dogs with serum
albumin concentration <3.0 g/dL. The feces of all dogs were screened for
helminths (fecal floatation), Giardia (immunofluorescent antibody testing
[IFA]), and Cryptosporidium (IFA), with no parasites detected in any case.
All dogs had exocrine pancreatic insufficiency excluded by fasted serum
trypsin-like immunoreactivity >5.0 ng/mL and hypoadrenocorticism
excluded by basal serum cortisol concentration >2 μg/mL or normal
response to ACTH stimulation. Dogs being treated with vitamin D or
calcium supplementation were excluded. Additionally, dogs that had
consumed a diet for >72 hours in the preceding 3 weeks that was not
formulated to meet Association of American Feed Control Officials
vitamin requirements (vitamin A, 5000 IU/kg dry matter basis [DMB];
vitamin D, 500 IU/kg DMB; vitamin E, 50 IU/kg DMB) were not eligible
for inclusion. Dogs being treated with glucocorticoids for >7 days
before enrollment were excluded from analysis. Age, breed, sex, body
weight (kg), and duration of illness (DOI) were recorded.
2.2 | Measurement of serum 25(OH)D
concentrations, ionized calcium, and parathyroid
hormone
Serum was collected from all dogs at the time of initial evaluation and
processed within 30 minutes of collection. In the majority of cases,
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serum was shipped on dry ice on the day of collection to the Michigan
State University's Diagnostic Center for Population and Animal Health
(DACPAH; MSU Diagnostic Center for Population and Animal Health,
Meridian Charter Township, Michigan) for completion of a Vitamin D
panel (measurement of serum 25[OH]D, ionized calcium [iCa], and
parathyroid hormone [PTH] concentrations). In a small number of
cases, serum was stored at −80C after processing and before being
shipped on dry ice to DACPAH for evaluation of 25(OH)D, iCa, and
PTH concentrations. Serum 25(OH)D, iCa, and PTH concentrations
previously have been shown to be stable under these conditions.20,21
The 25(OH)D concentration was measured using a commercially avail-
able radioimmunoassay kit, and serum ionized calcium concentrations
were measured using an ion-specific electrode. Serum PTH concentra-
tion was measured using an immunoradiometric assay, as previously
described.22
2.3 | Clinical activity, appetite, and body condition
scores
At the time of enrollment, owners were asked to score appetite, activity
level, vomiting, fecal consistency, fecal frequency, weight loss, and pruri-
tus for each dog. Applying the results of the serum biochemical profile
(serum albumin concentration) and abdominal ultrasound examination
(peritoneal effusion), and using the owner's scores, a canine chronic
enteropathy clinical activity index (CCECAI) score was calculated.23
Appetite scores also were recorded separately. Appetite score was
assigned as 0-3, where 0 = normal, 1 = mildly decreased, 2 = moderately
decreased, and 3 = severely decreased. Body condition score (BCS; scale
0-9) 24 was assigned for each dog by a single evaluator at the time of ini-
tial evaluation.
2.4 | Measurement of serum cholesterol,
alpha-tocopherol, and retinol concentrations
Serum cholesterol concentrations were recorded as measured by the
CSU Veterinary Diagnostic Laboratory using a Cobas Integra (Roche
Diagnostics Limited, West Sussex, UK) biochemistry analyzer. Serum
alpha-tocopherol (vitamin E) and retinol (vitamin A) concentrations
were batch measured on stored, aliquoted frozen serum samples using
high-performance liquid chromatography. Samples had been frozen
immediately after collection and processing, stored at −80C, and
thawed before analysis. Alpha-tocopherol and retinol are known to be
stable in serum for years.25
2.5 | Measurement of serum protein concentrations
Serum albumin concentration was measured routinely by the CSU
Veterinary Diagnostic Laboratory using a Cobas Integra (Roche Diag-
nostics Limited) biochemistry analyzer. Serum VDBP concentrations
were measured using a human-specific ELISA (My BioSource Inc, San
Diego, California), validated for measurement in the dog for research
by the kit manufacturer (see Supporting Information). The ELISA kit
uses mouse monoclonal antihuman highly purified human Gc globulin
(VDBP) as the capture antibody (Immunogen, Waltham, Massachu-
setts) and goat antihuman synthetic peptide ERGRDYEKNKVCK
(corresponding to amino acids 18-30 of human VDBP [near the N ter-
minal]) as the detection antibody (Immunogen). Serum samples had
been frozen immediately after collection, stored at −80C, and
thawed before analysis. Samples were stored for 2-18 months before
analysis; duration of time of sample storage before analysis was
recorded. Analysis and calculation of results were performed
according to manufacturer instructions.
2.6 | Markers of intestinal and systemic
inflammation
All dogs underwent gastroduodenoscopy and ileocolonoscopy for
evaluation of the intestinal mucosa and procurement of tissue sam-
ples. Histopathologic evaluation of intestinal tissue from clinical cases
(duodenum or ileum or both) was performed by a board-certified vet-
erinary pathologist (S.L.P.) and pathologist-in-training (A.S.-B.) blinded
to clinical data, clinicopathologic information, and groups. Biopsy sam-
ples were assessed as adequate for evaluation, and both evaluators
reviewed duodenal and ileal tissues and reached a consensus for the
presence and severity of morphologic criteria (villous stunting, epithe-
lial injury, crypt distension, lacteal dilatation (LD), mucosal fibrosis)
and inflammatory criteria (intraepithelial lymphocytes, lamina propria
eosinophils, lamina propria lymphocytes and plasma cells, lamina
propria neutrophils) based on the World Small Animal Veterinary
Association (WSAVA) guidelines.26 For the severity of each change,
scores were applied based on established criteria: 0 = normal, 1 = mild,
2 = moderate, 3 = marked. Individual scores were recorded, and the
total morphologic score and total inflammatory score per section of
intestine were recorded separately and then summed for a total
WSAVA score per section of intestine. Combined duodenal and ileal
total WSAVA scores also were recorded. Because vitamin D is a fat-
soluble vitamin, LD scores26 for each section of the intestine also
were recorded.
Plasma fibrinogen and serum C-reactive protein concentrations were
available for many of the dogs in the study as markers of systemic inflam-
mation. Quantitative plasma fibrinogen concentration was obtained at
the time of collection using the Clauss method (Tcoag TriniCLOT PT
Excel; Bray, Wicklow, Ireland). Serum C-reactive protein (CRP) concentra-
tion was determined using a commercially available ELISA (Tridelta
Development Limited, Maynooth, County Kildare, Ireland).
2.7 | Statistical analysis
For comparisons, groups were defined as dogs with low serum 25(OH)D
concentrations and dogs with normal serum 25(OH)D concentrations.
Dogs were considered low in vitamin D if serum concentration of
25(OH)D was <109 nmol/L, as defined by an established reference inter-
val (RI, 109-423 nmol/L), and normal if serum 25(OH)D concentration
fell within the RI. Groups were assessed for differences before clinical
and clinicopathological data analysis. To compare differences in sex and
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group, Fisher's exact test was used. To compare differences in age, body
weight, and DOI and group, the Mann-Whitney U was performed.
The distribution of clinical and clinicopathologic data was assessed
by the Shapiro-Wilk test. Normally distributed (parametric) variables
were compared using a t-test. Nonnormally distributed (nonparametric)
clinicopathologic variables were compared using a Mann-Whitney
U test. Bonferroni correction was applied to data to account for multi-
ple testing. Results are reported as mean ± standard deviation for the
parametric variables and median and range (minimum-maximum) for
nonparametric variables. Variables found to be significantly associated
with 25(OH)D based on the univariate Mann-Whitney U and t-test
results were placed into a multiple logistic regression analysis. Specifi-
cally, serum 25(OH)D concentration (decreased or normal) was the
response variable and the variables serum albumin, serum alpha-
tocopherol, serum cholesterol concentration, and CCECAI were used
as predictors. Serum CRP concentration was not included in the
model because of missing results. Backward elimination then was
used to decrease the number of predictors in the logistic regression
model.
To assess for correlations between vitamin D concentration and
iCa, PTH, and histopathological scores, a Spearman (rank-based) test
was performed. After Spearman testing, a Bonferroni correction was
performed to account for multiple testing. Finally, because of the
unknown effects of storage, a Pearson correlation was performed to
evaluate for correlation between serum sample storage time at −80C
and VDBP concentration. For Spearman and Pearson testing, a statis-
tically significant correlation score of (+/−) 0.3-0.5 was considered a
weak correlation, (+/−) 0.5-0.7 a moderate correlation, and (+/−)
0.7-1.0 a strong correlation.
Multiple logistic regression analysis was performed using R scien-
tific statistical software (R Foundation for Statistical Computing; ver-
sion 3.5.1). The remainder of the statistical analysis was performed
using GraphPad Prism scientific statistic software (Graph Pad Prism,
GraphPad Software, Inc, San Diego, California). Statistical significance
for all statistical comparisons was set at P < .05 and adjusted after
Bonferroni corrections.
3 | RESULTS
Thirty dogs with CIE were enrolled, 15 of which had low serum 25(OH)D
concentrations. The other 15 dogs had serum 25(OH)D concentrations
within the RI (Figure 1). Breeds in the low 25(OH)D group included
Bernese Mountain Dog (2), mixed breed dog (2), Labrador Retriever (2),
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F IGURE 1 Scatter dot plot of serum 25(OH)D in dogs with CIE with
and without low serum 25(OH)D. Horizontal bar represents median.
Interquartile range shown. CIE, chronic inflammatory enteropathy
TABLE 1 Clinical scores, BCS, and serum fat-soluble vitamins, cholesterol, proteins, and inflammatory markers in dogs with CIE and low or
normal 25(OH)D concentrations
Variable
Reference
interval
Low 25(OH)D (n = 15),
median (range) or mean ± SD
Normal 25(OH)D (n = 15),
median (range) or mean ± SD P-value*
25(OH)D (nmol/L) 109-423 15 (6-58) 195 (117-370)
CCECAI 0-24 12.3 ± 4.13 7.7 ± 3.54 .003
Appetite score 0-3 1 (0-3) 1 (0-3) .85
BCS 0-9 3.7 ± 1.16 3.9 ± 1.36 .78
α-Tocopherol (μg/mL) 5-24 11 (3.3-25) 23 (5.1-56) <.001
Retinol (μg/mL) 0.3-1 4 ± 2.54 4.7 ± 1.42 .36
Cholesterol (mg/dL) 130-300 80 (53-120) 198 (97-447) <.001
Albumin (g/dL) 3-4.3 1.6 (0.9-2.9) 3.3 (1.7-3.9) <.001a
VDBP (μg/mL) … 183 (132-299) 193 (119-718) .91
Fibrinogen (mg/dL)b 123-210 333 (201-835) 232 (146-523) .03
CRP (μg/mL)c 0-7.6 43.1 (9.5-60) 2.5 (0.3-60) .004
Abbreviations: BCS, body condition score; CIE, chronic inflammatory enteropathy; CCECAI, canine chronic enteropathy clinical activity index;
CRP, C-reactive protein; SD, standard deviation; VDBP, vitamin D-binding protein.
*P-value as assessed by Mann-Whitney U test for nonparametric variables (data presented as median (range) and t-test for parametric variables
(data presented as mean ± SD). Significance set at P < .005.
aRetained significance in multivariate analysis.
bData available from 10 dogs per group.
cData available from 13 dogs per group.
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Yorkshire Terrier (2), and 1 each of the following: Australian Shepherd,
English Bulldog, German Shepherd dog, Jack Russell Terrier, Pembroke
Welsh Corgi, Pug, and Rottweiler. Breeds in the normal 25(OH)D group
included mixed breed dog (6), Bernese Mountain Dog (2), Labrador
Retriever (2) and 1 each of the following: Cavalier King Charles Spaniel,
German Shepherd dog, German Shorthaired Pointer, Great Pyrenees,
and Siberian Husky. Groups were not different with regard to age, sex,
body weight, or DOI. Median age of low 25(OH)D dogs was 7 years
(range, 1-10 years) and normal 25(OH)D dogs was 5 years (range,
1-12 years). Five dogs in each group were spayed females; the
remaining dogs were neutered males. Median body weight was 19 kg
(range, 3-47 kg) in the low 25(OH)D group and 22 kg (range, 6-46 kg) in
the normal 25(OH)D group. Median DOI was 3 months (range,
1-11 months) in the low 25(OH)D group and 6 months (range,
1-24 months) in the normal 25(OH)D group. Two dogs in each group
had received glucocorticoids for <7 days before enrollment. At the time
of enrollment, 6 of 15 dogs in the low 25(OH)D group and 7 of 15 dogs
in the normal 25(OH)D group were being fed commercial over-the-
counter diets formulated to meet Association of American Feed Con-
trol Officials vitamin requirements. The remaining 9 of 15 dogs in the
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F IGURE 2 Scatter dot plot of serum α-tocopherol in dogs with
CIE with and without low serum 25(OH)D. Horizontal bar represents
median. Interquartile range shown. CIE, chronic inflammatory
enteropathy
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F IGURE 3 Scatter dot plot of serum albumin in dogs with CIE
with and without low serum 25(OH)D. Horizontal bar represents
median. Interquartile range shown. CIE, chronic inflammatory
enteropathy
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F IGURE 4 Scatter dot plot of serum cholesterol in dogs with CIE
with and without low serum 25(OH)D. Horizontal bar represents
median. Interquartile range shown. CIE, chronic inflammatory
enteropathy
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F IGURE 5 Scatter dot plot of serum C-reactive protein in dogs
with CIE with and without low serum 25(OH)D. Horizontal bar
represents median. Interquartile range shown. CIE, chronic
inflammatory enteropathy
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F IGURE 6 Scatter dot plot of serum retinol in dogs with CIE with
and without low serum 25(OH)D. Horizontal bar represents mean.
Standard deviation shown. CIE, chronic inflammatory enteropathy
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low 25(OH)D group and 8 of 15 dogs in the normal 25(OH)D group
were being fed various prescription veterinary gastrointestinal diets
also formulated to meet Association of American Feed Control Officials
vitamin requirements.
Summary statistics and P-values are presented in Table 1 for
CCECAI, appetite score, BCS, fat-soluble vitamins, cholesterol, serum
proteins, and serum inflammatory markers. In brief, dogs with low
serum 25(OH) concentrations had higher CCECAI scores (P = .003),
lower serum α-tocopherol concentrations (P < .001; Figure 2), lower
serum albumin concentrations (P < .001; Figure 3), lower serum cho-
lesterol concentrations (P < .001; Figure 4), and higher serum CRP
concentrations (P = .004; Figure 5) when compared to dogs with nor-
mal serum 25(OH)D concentrations. Serum concentrations of retinol
(Figure 6) and VDBP (Figure 7) were not different between groups
(P = .36 and P = .91, respectively). After backward elimination (using
alpha = .05), only albumin remained significant in the multiple regression
analysis model (odds ratio [OR], 0.022; P = .002). The OR represents the
odds of decreased serum 25(OH)D concentration corresponding to a
1 unit (g/dL) increase in serum albumin concentration.
Gastroduodenoscopy and ileocolonoscopy was attempted in all
dogs. The ileum could not be successfully biopsied in 2 dogs in the
low 25(OH)D group and 2 dogs in the normal 25(OH)D group, and
thus ileal tissue was not available for evaluation in those cases. Sum-
mary statistics and P-values for histopathologic variables are pres-
ented in Table 2. In brief, a moderate negative correlation (rho value,
−0.5516) was observed between serum 25(OH)D concentrations and
total morphologic scores in the duodenum, and a moderate negative
correlation (rho value, −0.5108) was observed between serum
25(OH)D concentrations and total inflammatory scores for the duode-
num (P = .002 and P = .004, respectively). In addition, overall WSAVA
scores for duodenum were moderately negatively correlated (rho
value, −0.613; P < .001), and overall WSAVA scores for combined
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F IGURE 7 Scatter dot plot of serum vitamin D-binding protein in
dogs with CIE with and without low serum 25(OH)D. Horizontal bar
represents median. Interquartile range shown. CIE, chronic
inflammatory enteropathy
TABLE 2 Histopathology scores in dogs with chronic inflammatory enteropathy and low or normal 25(OH)D concentrations
Variable Group Median IQR Min Max Spearman's correlation score P-value*
LD—duodenum Low 25(OH)D 1 1 0 2 −0.2842 .13
Normal 25(OH)D 0 1 0 2
LD—ileuma Low 25(OH)D 1 2 0 3 −0.5015 .009
Normal 25(OH)D 0 0 0 2
Morphologic scoreb—duodenum Low 25(OH)D 3 5 0 10 −0.5516 .002
Normal 25(OH)D 3 5 0 10
Morphologic scoreb—ileuma Low 25(OH)D 2 3 0 6 −0.3903 .05
Normal 25(OH)D 1 4 0 8
Inflammatory scorec—duodenum Low 25(OH)D 5 3 2 8 −0.5108 .004
Normal 25(OH)D 4 2 1 8
Inflammatory scorec—ileuma Low 25(OH)D 2 3 0 5 0.0066 .97
Normal 25(OH)D 2 4.5 0 7
Overall WSAVA score—duodenum Low 25(OH)D 11 4 2 15 −0.613 <.001
Normal 25(OH)D 7 5 1 18
Overall WSAVA score—ileuma Low 25(OH)D 5 4.5 1 11 −0.2199 .28
Normal 25(OH)D 3 8 0 14
Overall WSAVA score—duodenum + ileuma Low 25(OH)D 16 10 8 23 −0.5685 .002
Normal 25(OH)D 9 13.5 2 32
Abbreviations: IQR, interquartile range; Low 25(OH)D, low 25-hydroxyvitamin D (<109 nmol/L); Normal 25(OH)D, normal 25-hydroxyvitamin D
(109-423 nmol/L); LD, lacteal dilatation; WSAVA, World Small Animal Veterinary Association.
*P-value as assessed by Spearman correlation. Significance set at P < .004.
aScores available for 13 dogs per group.
bTotal score for villous stunting, epithelial injury, crypt distension, lacteal dilatation, and mucosal fibrosis.
cTotal score for intraepithelial lymphocytes, lamina propria lymphocytes/plasma cells, lamina propria eosinophils, and lamina propria neutrophils.
6 WENNOGLE ET AL.
duodenum and ileum were moderately negatively correlated (rho
value, −0.5685; P = .002) with serum 25(OH)D concentrations.
Serum PTH concentration was moderately negatively correlated
(rho value, −0.6827) with serum 25(OH)D concentration (P < .001).
Serum iCa concentration was strongly positively correlated (rho value,
0.7343) with serum 25(OH)D concentration (P < .001). Serum VDBP
concentration was not correlated with the duration of time the sample
was stored (P = .54).
4 | DISCUSSION
Although decreased serum vitamin D concentrations have been well
documented in dogs with CE and PLE, the etiology has been relatively
unexplored. In our study, we examined a variety of variables related
to the proposed mechanisms of vitamin D deficiency in humans with
IBD, which include lack of PO intake, malabsorption of fat, direct loss
of vitamin D through the gastrointestinal tract, and an active inflam-
matory state resulting in decreased production of vitamin D. We
found CCECAI scores and CRP concentrations were higher, whereas
serum α-tocopherol, cholesterol, and albumin concentrations were
lower in dogs with CIE and low serum 25(OH)D concentrations when
compared to dogs with CIE and normal serum 25(OH)D concentra-
tions. In addition, duodenal morphologic and inflammatory scores, and
overall WSAVA scores in the duodenum and combined duodenum
and ileum, were negatively correlated with serum 25(OH)D concen-
trations in dogs with CIE.
Higher CCECAI scores were observed in CIE dogs with low serum
vitamin D concentrations when compared to CIE dogs with normal
serum vitamin D concentrations. Similarly, humans with IBD and low
serum vitamin D concentrations are reported to have worse pain,
higher disease activity index scores, and lower quality of life scores
when compared to IBD patients with normal serum vitamin D concen-
trations.9,27 The appetite scores as a component of CCECAI were
evaluated in isolation and were not different between groups. In fact,
the owners of an equal number of dogs in each group (n = 6)
described their dogs as having normal appetite (appetite score 0). This
observation would suggest that poor PO intake of vitamin D is
unlikely to be the sole explanation for why some dogs with CIE have
low serum vitamin D concentrations and others do not, but precise
quantification of dietary vitamin D intake would be needed to defini-
tively make this conclusion.
Serum cholesterol and alpha-tocopherol (vitamin E) concentrations
were lower in low 25(OH)D CIE dogs when compared to dogs with
CIE and normal serum 25(OH)D concentrations. In addition, based on
the laboratory-established RI, 2 dogs in the low 25(OH)D group had
subnormal vitamin E with serum concentrations <5 μg/mL. Serum reti-
nol (vitamin A) concentrations fell within or above the normal RI for all
dogs in the study and were not different between CIE dogs with low
serum 25(OH)D concentrations compared to CIE dogs with normal
serum 25(OH)D concentrations.
The exact explanation for low serum cholesterol and vitamin E
concentrations in dogs with CIE and low serum 25(OH)D
concentrations is unknown. In humans, cholesterol is fundamental to
the endogenous synthesis of vitamin D after sunlight exposure.28
However, because endogenous synthesis of vitamin D is thought to
be absent to limited in the dog,29 it is unlikely that hypo-
cholesterolemia associated with intestinal disease30 was the direct
cause of low serum 25(OH)D concentration in our cases. Intestinal
absorption of dietary cholesterol and fat-soluble vitamins (including A,
D, E, and K) requires emulsification, hydrolysis, and micellization as
well as adequate concentrations of pancreatic lipase and bile acids in
the intestinal lumen. Therefore, dietary fat malabsorption because of
a lack of bile salts, lymphatic dysfunction, or other causes may be an
explanation for the decreased serum concentrations of cholesterol
and vitamin E in dogs with low serum 25(OH)D concentration and
CIE.31,32 To further investigate the possibility of fat malabsorption in
dogs with CIE and low serum 25(OH)D concentration, a coefficient of
fat absorption test of feces or malabsorption blood test33 could be
performed and compared between dogs with CIE and low serum
25(OH)D and normal serum 25(OH)D concentrations. Although serum
vitamin A concentrations were not different between groups, mea-
surement of hepatic vitamin A stores using the relative dose response
test was demonstrated to be more sensitive than serum retinol con-
centration for the detection of vitamin A deficiency in humans with
CD.34 Therefore, it is possible that measurement of hepatic vitamin A
stores may have been a more accurate way to assess vitamin A status
in our patients. In addition to malabsorption, proposed mechanisms of
fat-soluble vitamin deficiencies in humans with IBD include consump-
tion of antioxidants by proinflammatory radicals, enteric loss, and
decreased nutrient intake.27,35
Several of the dogs in our study had serum α-tocopherol and reti-
nol concentrations above the laboratory-established RI. This finding is
similar to a recent study evaluating lipid-soluble vitamins in dogs with
exocrine pancreatic insufficiency36 and deserves further study.
To investigate enteric loss as the cause of low serum vitamin D
concentrations in dogs with CIE, we considered that vitamin D and its
metabolites are largely bound to VDBP in circulation. A much lower
proportion is bound to albumin in serum, and <1% of vitamin D circu-
lates unbound.16 Serum concentrations of VDBP only have been stud-
ied in 1 cohort of children with IBD. This study found that serum
VDBP concentrations were lower in children with IBD when com-
pared to healthy controls, but no correlation between serum VDBP
and serum 25(OH)D concentrations was found.17 Although loss of VDBP
has been proposed as a cause of decreased 25(OH)D concentrations in
dogs with hypoalbuminemia secondary to IBD,2 we are not aware of any
previous study of serum VDBP concentrations in dogs with CIE. In our
study, we found serum VDBP concentrations were similar between the
low 25(OH)D and normal 25(OH)D groups. Because we do not have an
established RI for serum VDBP concentration in dogs, we do not know
how these results compare to what would be found in a population of
healthy dogs. A relationship between serum albumin and 25(OH)D con-
centrations previously has been demonstrated in humans18 and dogs2
with IBD. In our study, CIE dogs with low serum 25(OH)D concentrations
had serum albumin concentrations lower than CIE dogs with normal
serum 25(OH)D concentrations. In fact, only 1 dog with serum 25(OH)D
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concentrations below the laboratory-established RI for 25(OH)D had a
serum albumin concentration >2.0 g/dL. Enteric loss of albumin may be
directly related to decreased serum 25(OH)D concentrations in dogs with
CIE and hypoalbuminemia. However, because about only 10%-15% of
vitamin D and its metabolites circulate bound to albumin, an alternative
explanation would be that the relationship between serum albumin
and 25(OH)D concentrations is not causal but representative of
underlying pathophysiology that results in the decrease of both, such
as lymphatic dysfunction or alterations in intestinal permeability and
absorption.
Finally, we evaluated markers of both intestinal and systemic
inflammation to investigate the hypothesis of an active inflammatory
state contributing to low serum vitamin D concentrations in dogs with
CIE. Importantly, recent studies of dogs with CIE have determined the
clinical relevance of morphologic changes in the intestine with regard to
clinical scores,37 hypoalbuminemia,37,38 and response to treatment.39
Therefore, we elected to evaluate the morphologic and inflammatory
changes in the intestine separately and together. In a previous study,
total WSAVA scores were negatively associated with serum 25(OH)D
concentrations in dogs with CE.19 In our study, low serum 25(OH)D con-
centrations were moderately correlated with higher scores for morpho-
logic and inflammatory changes in the duodenum, as well as with overall
WSAVA scores for the duodenum and combined duodenum and ileum.
In our study, morphologic changes in the duodenum consisting of villous
stunting, epithelial injury, crypt distension, LD, and mucosal fibrosis were
moderately negatively correlated with serum 25(OH)D concentrations.
Lacteal dilatation also was evaluated in isolation, and ileal LD scores
showed a moderate negative correlation with serum 25(OH)D con-
centration that was not significant after correction for multiple test-
ing. Histopathologic interpretation of LD has limitations, particularly
in endoscopic samples. Lymphangiectasia can be segmental and, in
some cases, confined to deeper layers of the intestine that may
not be adequately sampled by endoscopic biopsies, and, therefore,
lymphatic abnormalities may have been underestimated.40 Duodenal
inflammatory scores also were moderately negatively correlated with
serum 25(OH)D concentrations, as well as total WSAVA scores in the
duodenum and combined duodenal and ileum. Furthermore, serum
CRP concentrations were higher in dogs with decreased 25(OH)D
concentrations, suggesting that systemic inflammation may play in a
role in the development of low serum vitamin D concentrations in
dogs with CIE. We suspect that both systemic and intestinal inflam-
mation may play a role in the development of low serum vitamin D
concentrations in dogs with CIE. However, our study suggests that
morphologic changes also play a role, adding to the growing evidence
of the importance of morphologic changes in the intestine in cases
of CIE.
As expected, serum 25(OH)D concentrations were positively corre-
lated with serum ionized calcium concentrations and negatively corre-
lated with serum PTH concentrations. Ten dogs in in the low 25(OH)D
group had ionized hypocalcemia, defined by serum iCa concentrations
<1.25 mmol/L. Apparent nutritional secondary hyperparathyroidism was
diagnosed in 10 dogs with low serum vitamin D concentrations, based
on serum PTH concentrations >5.8 pmol/L. This is the appropriate
physiologic response to a vitamin D deficient state,41 but it was not pre-
sent in all dogs.
Our study had some limitations. First, the ileum was not biopsied
in 2 dogs in each group. Because pathology can differ among sections
of intestine,42,43 this may have influenced our results. Also, despite
the use of a blinded pathologist and a pathologist-in-training to come
to a consensus score using WSAVA standards, histopathologic inter-
pretation of the intestine still is considered relatively subjective,44 and
interobserver variation exists.45 Serum CRP and fibrinogen concentra-
tions were not measured in all dogs, because the study protocol was
amended to include these variables after several dogs had already
been enrolled. This may have affected our results for these variables.
Because an RI has not been established for serum VDBP concentra-
tions in healthy dogs, no conclusions can be drawn about the VDBP
concentrations in dogs with CIE compared to healthy controls. The
inclusion of a robust healthy control group, particularly for serum con-
centrations of fat-soluble vitamins as well as VDBP could have
strengthened our results. Additionally, although the ELISA kit for
detection of VDBP in canine serum has been validated for research
use in dogs based on high homology between human and canine
VDBP sequences as well as positive reactivity with 35 healthy control
canine samples, it is not approved for diagnostic purposes at this time.
Two dogs in each group had received glucocorticoids for <7 days
before enrollment. Although glucocorticoids are known to affect vita-
min D metabolism at several different levels, studies have shown that
short-term administration (<14 days) of glucocorticoids did not affect
serum concentrations of 25(OH)D in humans.46 Although we cannot
be certain that vitamin D metabolism in dogs is equally unaffected,
because 2 dogs were present in each group, we do not expect this
affected the results importantly. Finally, although radioimmunoassay
for serum 25(OH)D concentration is the most widely used approach
to measure whole-body vitamin D status,5 liquid chromatography-
mass spectrometry is considered by some to be a more accurate form
of measurement.4
The pathogenesis of low serum vitamin D concentrations in dogs
with CIE is likely multifactorial. A better understanding of the etiology is
desirable because it may improve our understanding of gastrointestinal
disease in dogs and improve our ability to detect and treat dogs with low
serum vitamin D concentrations and CIE. Moreover, vitamin D supports
innate lymphoid cells, regulates tight junction expression, and plays a key
role in gastrointestinal microbial health such that decreased serum
vitamin D concentrations can negatively affect the intestinal immune
system, impair gastrointestinal barrier function, and result in dysbiotic
microbial communities.47 Therefore, identification of decreased serum
vitamin D concentrations in patients with CIE may be important for gen-
eral gastrointestinal health. Based on our study, intestinal fat malabsorp-
tion, potentially related to lymphatic dysfunction or altered intestinal
permeability, deserves further study in dogs with CIE and low serum
25(OH)D concentrations. Additionally, based on our preliminary evalua-
tion, loss of VDBP does not appear to be a major mechanism of low
serum vitamin D concentrations, but this requires confirmation in a
larger group of dogs, including healthy controls. The effects of sys-
temic and intestinal inflammation as well as morphologic changes in
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the intestine on serum vitamin D concentrations were identified as
important areas of study in the mechanism of low serum 25(OH)D
concentrations among dogs with CIE. Causal relationships cannot be
inferred from our study. Further evaluation, particularly of serum con-
centrations of the other fat-soluble vitamins and VDBP, in a larger
number of affected dogs as well as in healthy controls is necessary to
be able to better understand the cause of low serum 25(OH)D con-
centrations in dogs with CIE.
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